Regular Home-use of Dual-light Photodynamic Therapy in the Management of Chronic Stage III-IV Periodontitis
Sponsored by Koite Health Oy
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Started 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Periodontal disease stage III-IV, according to criteria the American Academy of Periodontology (AAP) with at least 3 mm interdental clinical attachment level (CAL) in the site of greatest loss.
- ≥ 18 years old
- Presence of ≥20 teeth, including implants
- Agreement to participate in the study and to sign a written consent form
- Able to co-operate with the treatment protocol and avoid any other oral hygiene measures outside of the study protocol
Exclusion Criteria
- Grade A or C periodontitis
- Presence of any physical limitation or restriction that might restrict Lumoral use
- Pregnancy or lactation
- Active smoking
- Medicated diabetes mellitus (DM)
- Any systemic disease (e.g., wound healing dysfunctions) that could alter the progression of periodontal disease
- Use of antibiotics within 4 weeks week prior study
- Periodontal treatment within 3 months prior study
- Removable major prosthesis or major orthodontic appliance
- A need for a hopeless teeth extraction, or open cavities in need for immediate endodontic treatment